Catalyst Pharmaceuticals Files 8-K
Ticker: CPRX · Form: 8-K · Filed: Feb 26, 2025 · CIK: 1369568
| Field | Detail |
|---|---|
| Company | Catalyst Pharmaceuticals, Inc. (CPRX) |
| Form Type | 8-K |
| Filed Date | Feb 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K, regulatory
Related Tickers: CPRX
TL;DR
Catalyst Pharma filed an 8-K on Feb 26, 2025, updating corporate info.
AI Summary
Catalyst Pharmaceuticals, Inc. filed an 8-K on February 26, 2025, reporting other events and financial statements. The filing details the company's corporate information, including its incorporation in Delaware and its principal executive offices located in Coral Gables, Florida.
Why It Matters
This filing provides an update on Catalyst Pharmaceuticals' corporate structure and reporting, which is essential for investors to stay informed about the company's regulatory compliance and operational details.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not contain information that inherently increases risk.
Key Numbers
- 001-33057 — Commission File Number (Identifies the company's filing with the SEC)
- 76-0837053 — I.R.S. Employer Identification No. (Company's tax identification number)
Key Players & Entities
- CATALYST PHARMACEUTICALS, INC. (company) — Registrant
- February 26, 2025 (date) — Date of Earliest Event Reported
- Delaware (jurisdiction) — State of incorporation
- Coral Gables, Florida (location) — Address of principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of February 26, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on February 26, 2025.
In which state is Catalyst Pharmaceuticals, Inc. incorporated?
Catalyst Pharmaceuticals, Inc. is incorporated in Delaware.
What is the company's principal executive office address?
The company's principal executive offices are located at 355 Alhambra Circle, Suite 801, Coral Gables, Florida, 33134.
What is Catalyst Pharmaceuticals, Inc.'s Commission File Number?
Catalyst Pharmaceuticals, Inc.'s Commission File Number is 001-33057.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 26, 2025 regarding CATALYST PHARMACEUTICALS, INC. (CPRX).